Evidence-Based Opioid Recovery
Heroin Addiction Treatment at Phuket Island Rehab
From medically supervised detox to medication-assisted treatment and psychotherapy, our residential programme provides the full continuum of evidence-based heroin addiction care.
Table of Contents
Evidence-Based Heroin Addiction Treatment: From Detox to Sustained Recovery
Effective heroin addiction treatment follows a structured continuum of care designed to address the neurobiological, psychological, and social dimensions of opioid use disorder simultaneously. The science of heroin treatment has advanced substantially over the past two decades, with robust evidence supporting specific pharmacological and psychotherapeutic interventions that dramatically improve recovery rates compared to unassisted attempts.
Understanding the treatment process — what each phase involves, why it matters, and what outcomes to expect — helps individuals and families make informed decisions and reduces the anxiety that often prevents people from seeking help. Heroin addiction responds to treatment, and sustained recovery is an achievable clinical outcome.
Phase 1: Medical Detoxification
Detoxification is the essential first step, managing the acute withdrawal syndrome that occurs when heroin use stops. While heroin withdrawal is rarely life-threatening (unlike alcohol withdrawal), its intensity drives the majority of relapse during early recovery and is the primary barrier to treatment engagement.
At Phuket Island Rehab, medical detoxification uses evidence-based protocols that prioritise both safety and comfort. The two primary pharmacological approaches are buprenorphine-assisted detox and symptom-directed management.
| Detox Approach | Mechanism | Best Suited For |
|---|---|---|
| Buprenorphine taper | Partial mu-opioid agonist; manages withdrawal with ceiling effect on respiratory depression | Most heroin-dependent individuals; allows gradual taper over 7–14 days |
| Clonidine-based protocol | Alpha-2 adrenergic agonist; reduces autonomic hyperactivity without opioid receptor activation | Individuals transitioning to naltrexone; those preferring non-opioid detox |
| Symptomatic adjuncts | Anti-emetics, loperamide, NSAIDs, sleep aids, muscle relaxants | All protocols; targeted at specific withdrawal symptoms |
The Clinical Opiate Withdrawal Scale (COWS) is used to objectively assess withdrawal severity at regular intervals, allowing the medical team to titrate medications in real time. This symptom-triggered approach reduces total medication requirements while maintaining comfort.
Phase 2: Medication-Assisted Treatment (MAT)
MAT is the gold standard of heroin addiction treatment, with decades of research demonstrating that it reduces illicit opioid use, overdose death, criminal activity, and infectious disease transmission while improving treatment retention, social functioning, and quality of life.
Three medications have strong evidence for opioid use disorder. Buprenorphine (Suboxone, Subutex) partially activates mu-opioid receptors, preventing withdrawal and craving without producing the euphoric high of full agonists. Its ceiling effect on respiratory depression makes it significantly safer than methadone. Naltrexone (Vivitrol) blocks opioid receptors entirely, preventing heroin from producing any effect if used. The extended-release injectable formulation eliminates adherence concerns. Methadone, a full mu-opioid agonist, is used in highly supervised settings for individuals who do not respond to buprenorphine.
Phase 3: Psychotherapeutic Rehabilitation
Medication addresses the neurobiological dimension of dependence; psychotherapy addresses the psychological and behavioural dimensions that sustain addictive behaviour patterns.
At Phuket Island Rehab, the residential rehabilitation programme integrates several evidence-based therapeutic modalities. Cognitive-behavioural therapy (CBT) helps clients identify the triggers, thought patterns, and situational cues that drive heroin use, and develops alternative coping responses. Contingency management reinforces positive behaviours (clean urine screens, therapy attendance) with tangible rewards — a technique with particularly strong evidence in opioid use disorder treatment.
Trauma-focused therapy is integrated because a significant proportion of heroin users have experienced childhood adversity, sexual trauma, or other traumatic events. Unaddressed trauma is one of the strongest predictors of relapse in opioid use disorder. Eye movement desensitisation and reprocessing (EMDR) and trauma-focused CBT are both available within the programme.
Motivational interviewing strengthens intrinsic recovery commitment. Group therapy provides peer support and accountability. Mindfulness-based relapse prevention trains clients to observe craving without acting on it — building the critical gap between impulse and action.
| Therapy | Target | Evidence Level |
|---|---|---|
| CBT | Trigger identification, coping skills, relapse prevention | Strong (multiple RCTs) |
| Contingency Management | Behavioural reinforcement of abstinence | Strong (strongest evidence for opioid use disorder) |
| Trauma-focused therapy | Co-occurring PTSD and trauma | Strong for dual diagnosis |
| Motivational Interviewing | Ambivalence resolution, treatment engagement | Moderate-strong |
| Mindfulness-based relapse prevention | Craving management, emotional regulation | Emerging evidence, promising results |
Addressing Co-occurring Conditions
Heroin use disorder rarely exists in isolation. Co-occurring conditions that must be identified and treated include depression and anxiety (present in 40–60 percent of opioid-dependent individuals), PTSD (25–50 percent), hepatitis C (high prevalence from injection drug use), chronic pain (a frequent driver of initial opioid use), and polysubstance use disorders involving alcohol, benzodiazepines, or stimulants.
Integrated treatment that addresses all co-occurring conditions simultaneously produces significantly better outcomes than sequential or siloed treatment. The clinical team at Phuket Island Rehab conducts comprehensive assessment at intake to identify every relevant condition and designs treatment protocols accordingly.
Aftercare and Long-Term Recovery
Heroin addiction treatment does not end at discharge. The post-acute withdrawal period (weeks to months of fatigue, dysphoria, insomnia, and intermittent craving) is a high-risk period that requires ongoing support. Phuket Island Rehab’s aftercare programme includes structured check-ins, continued therapeutic support, and relapse prevention monitoring.
Long-term MAT (buprenorphine or naltrexone maintenance) is recommended for many individuals with heroin use disorder, as research shows that longer durations of medication treatment are associated with lower relapse rates. The decision about MAT duration is individualised and made collaboratively between the client and clinical team.
Frequently Asked Questions
How long does heroin addiction treatment take?
Medical detox typically takes 7 to 14 days. Residential rehabilitation programmes range from 30 to 90 days, with longer stays producing better outcomes for opioid use disorder. Aftercare and MAT may continue for months to years depending on individual needs. Research consistently shows that treatment durations under 90 days are associated with higher relapse rates for heroin addiction.
Is buprenorphine just replacing one addiction with another?
No. Buprenorphine is a partial agonist that stabilises opioid receptors without producing the euphoric high, compulsive use, or functional impairment of heroin. It is analogous to insulin for diabetes — a medication that manages a chronic neurobiological condition. Research shows that buprenorphine maintenance reduces overdose death by 50 percent or more, reduces illicit opioid use, and improves social and occupational functioning.
What are the chances of recovery from heroin addiction?
With comprehensive treatment (MAT plus psychotherapy), approximately 40 to 60 percent of individuals achieve sustained remission at one year. Longer treatment engagement, MAT adherence, aftercare participation, and strong social support all improve outcomes. Even individuals who relapse benefit from treatment — each treatment episode strengthens recovery skills and reduces overall use.
Can heroin addiction be treated without medication?
While non-pharmacological treatment exists, research consistently shows that MAT produces significantly better outcomes for opioid use disorder than counselling alone. Guidelines from the WHO, NICE, and ASAM all recommend MAT as first-line treatment. Medication-free approaches have higher relapse and overdose rates and are generally recommended only for individuals who have strong, informed preferences against MAT after understanding the evidence.
Does Phuket Island Rehab offer MAT for heroin addiction?
Yes. The programme offers both buprenorphine and naltrexone as part of individualised treatment protocols, integrated with comprehensive psychotherapy and residential rehabilitation. The clinical team helps each client understand the evidence for and against each medication option and supports informed, collaborative treatment decisions.
Clinically reviewed by: Dr. Ponlawat Pitsuwan, Physician
Clinical entities referenced: Medication-assisted treatment (MAT) · Buprenorphine (Suboxone/Subutex) · Naltrexone (Vivitrol) · Methadone · Clinical Opiate Withdrawal Scale (COWS) · Mu-opioid receptor · Partial agonist pharmacology · Clonidine · Cognitive-behavioural therapy (CBT) · Contingency management · EMDR · Trauma-focused CBT · Motivational interviewing · Mindfulness-based relapse prevention · Post-acute withdrawal syndrome · DSM-5 opioid use disorder · Hepatitis C · WHO/NICE/ASAM guidelines